[Other] 892-P: Impact of ReCET Therapy on Continuous Glucose Monitoring (CGM) Metrics in Type 2 Diabetes—Insights from the REGENT-1 Trial

Shubham@0 Post time 1 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-07-26 17:25

Reward20points

journal：Diabetes

Authors：DAVID N. O'NEAL; JOHN APOSTOLOPOULOS; ADRIAN SARTORETTO; SUJIEVVAN CHANDRAN; RHYS VAUGHAN; BRONTE HOLT; GEORGINA CAMERON; BARHAM ABUDAYYEH; RICHARD E. PRATLEY; CHRISTOPHER H. SORLI; ELIF I. EKINCI

Published date：2025-6-20

DOI：10.2337/db25-892-p

PDF link：https://diabetesjournals.org/dia ... erapy-on-Continuous

Article link：https://doi.org/10.2337/db25-892-p

Article Source：American Diabetes Association。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

Shubham@0 Lv.3

Intermediate member

post
reply
points
390

[Other] 892-P: Impact of ReCET Therapy on Continuous Glucose Monitoring (CGM) Metrics in Type 2 Diabetes—Insights from the REGENT-1 Trial Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] 892-P: Impact of ReCET Therapy on Continuous Glucose Monitoring (CGM) Metrics in Type 2 Diabetes—Insights from the REGENT-1 Trial